hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Microbicide Developer Receives License for Novel HIV Microbicide Candidate from Merck & Co., Inc.

Author: International Partnerships for Microbicides, Published on: 11 March 2008

…Merck & Co., Inc., has agreed to provide a royalty-free license to the non-profit International Partnership for Microbicides (IPM) to develop a novel antiretroviral compound for use as a potential vaginal microbicide…“Merck deserves recognition for its exemplary commitment to HIV prevention research,” says Dr. Zeda Rosenberg, CEO of the International Partnership for Microbicides. “…We’re working toward the day when millions of women around the world will have access to safe and effective microbicides — and partnerships like this will help us get there”…[refers also to IPM partners Gilead Sciences, Bristol-Myers Squibb, and Tibotec Pharmaceuticals (part of Johnson & Johnson)]

Read the full post here

Related companies: Bristol-Myers Squibb Gilead Sciences Johnson & Johnson Merck Tibotec (part of Johnson & Johnson)